Welsh start-up Mikota has secured funding from Innovate UK.
The Welsh start-up biotechnology and medical device company is looking to commercialise a new and novel hemocyanin extracted from the invasive slipper limpet with the support of Innovate UK funding.
The Innovate UK funding follows on from an earlier hemocyanin feasibility study that was funded by LEADER funding from PLANED and Sustainable Development Funding from the Pembrokeshire Coast National Park Authority.
The medicines manufacturing grant is in collaboration with Cardiff University.
The project has allowed Mikota to take on three Professional Training Year students, part of the company’s employability program to get students “employment ready” at their time of graduation.
The Innovate UK grant award was part of a monumental last quarter of 2018 for the company with the signing of an MOU with a large global medical device manufacturer and its multi-city trade mission to Korea, which has become a key export destination for marine sourced products.
Based in Pembroke Dock, Wales, Mikota harvests slipper limpets from the Welsh coast to extract hemocyanin for use in anti-cancer, immunology and anti-body creation.